NASDAQ:REVBW

Revelation Biosciences (REVBW) Stock Price, News & Analysis

$0.02
0.00 (0.00%)
(As of 05/13/2024 ET)
Today's Range
$0.0198
$0.0198
50-Day Range
$0.01
$0.03
52-Week Range
$0.01
$0.03
Volume
1,106 shs
Average Volume
66,613 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Revelation Biosciences

Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-SSI, a potential therapy for the prevention and treatment of surgical sit infection; GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was founded in 2020 and is based in San Diego, California.

REVBW Stock Price History

REVBW Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive REVBW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Revelation Biosciences and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:REVBW
Fax
N/A
Employees
9
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

  • Mr. James M. Rolke (Age 55)
    CEO & Director
    Comp: $649.25k
  • Mr. Chester Stanley Zygmont III (Age 44)
    CFO & Corporate Secretary
    Comp: $479.14k
  • Ms. Sandra Vedrick
    Vice President of Human Resources & Investor Relations
  • Ms. Carol Odle
    Senior Director of Clinical Projects

REVBW Stock Analysis - Frequently Asked Questions

How have REVBW shares performed in 2024?

Revelation Biosciences' stock was trading at $0.0106 on January 1st, 2024. Since then, REVBW stock has increased by 86.8% and is now trading at $0.0198.
View the best growth stocks for 2024 here
.

How do I buy shares of Revelation Biosciences?

Shares of REVBW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:REVBW) was last updated on 5/14/2024 by MarketBeat.com Staff

From Our Partners